USTR Calls for Public Comments on Tariffs on Remaining Chinese Imports
The Office of the U.S. Trade Representative has published a list of "essentially all products not currently covered" by Section 301 tariffs, with the exception of pharmaceuticals, certain chemicals made into prescription drugs, rare earth minerals and critical minerals. The office is seeking public comment on hiking tariffs on these goods, which represented approximately $300 billion in imports last year.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Product exclusions previously granted will still be spared the additional 25 percent duty, the USTR said. The office said it might add tariffs of up to 25 percent on 3,805 full and partial tariff subheadings. Toys, apparel, home goods, shoes, electronics, sporting goods, chemicals and child safety seats are all on the list.
The notice also addresses how foreign-trade zones are treated. "Any merchandise subject to the increased tariffs admitted into a U.S. foreign trade zone on or after the effective date of the increased tariffs, except those eligible for admission under 'domestic status' as defined in 19 CFR 146.43, would have to be admitted as 'privileged foreign status' as defined in 19 CFR 146.41, and would be subject upon entry for consumption to the additional duty."
Written comments are due by June 17. On that date, the Section 301 Committee will convene a public hearing at the International Trade Commission.